Insights

Innovative Product Pipeline Aequus Pharmaceuticals is actively developing and commercializing differentiated products in specialized therapeutic areas such as neurology, ophthalmology, and psychiatry. This focus on innovative delivery systems aimed at improving medication adherence presents opportunities to establish partnerships with healthcare providers and clinics seeking advanced therapeutic solutions.

Recent Product Launches The successful launch of Zimed PF in August 2023, with recognized revenue of over $65,000, indicates a growing market presence and sales momentum. This success presents upselling or cross-selling opportunities within ophthalmic and glaucoma markets, especially targeting healthcare providers managing ocular health conditions.

Strategic Partnerships Aequus is building its pipeline via licensing and distribution agreements, including partnerships with Scope Ophthalmics and Optical Prism. These collaborations open avenues for business development by offering co-marketing, distribution, or licensing opportunities in niche ophthalmic and neurology markets across Canada and potentially expanding globally.

Market Expansion Potential With its goal to commercialize proprietary programs domestically and form international strategic alliances, there is potential to introduce Aequus’ innovative therapies into new geographic markets. These expansion efforts could be targeted towards specialty clinics, hospitals, and healthcare networks seeking differentiated ophthalmic and neurological treatments.

Financial and Funding Growth Although current revenues are modest, Aequus’ recent product approvals and ongoing pipeline development suggest future sales growth. Engagement with investors and stakeholders interested in innovative pharma companies could facilitate additional funding or partnership opportunities to accelerate sales and market reach.

Similar companies to Aequus Pharmaceuticals

Aequus Pharmaceuticals Tech Stack

Aequus Pharmaceuticals uses 8 technology products and services including Google Hosted Libraries, Tagembed, Cloudflare, and more. Explore Aequus Pharmaceuticals's tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • Tagembed
    Content Management System
  • Cloudflare
    Content Management System
  • Google Fonts API
    Font Scripts
  • Mapbox GL JS
    Maps
  • reCAPTCHA
    Security
  • Google Analytics
    Web Analytics
  • OpenResty
    Web Servers

Media & News

Aequus Pharmaceuticals's Email Address Formats

Aequus Pharmaceuticals uses at least 1 format(s):
Aequus Pharmaceuticals Email FormatsExamplePercentage
FLast@aequuspharma.caJDoe@aequuspharma.ca
46%
First.Last@aequuspharma.caJohn.Doe@aequuspharma.ca
5%
First@aequuspharma.caJohn@aequuspharma.ca
3%
FLast@aequuspharma.caJDoe@aequuspharma.ca
46%

Frequently Asked Questions

What is Aequus Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Aequus Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aequus Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's official website is aequuspharma.ca and has social profiles on LinkedInCrunchbase.

What is Aequus Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Aequus Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of January 2026, Aequus Pharmaceuticals has approximately 1 employees across 1 continents, including North America. Key team members include Executive Clinical Specialist: D. F.Research Analyst: I. P.. Explore Aequus Pharmaceuticals's employee directory with LeadIQ.

What industry does Aequus Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Aequus Pharmaceuticals use?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's tech stack includes Google Hosted LibrariesTagembedCloudflareGoogle Fonts APIMapbox GL JSreCAPTCHAGoogle AnalyticsOpenResty.

What is Aequus Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's email format typically follows the pattern of FLast@aequuspharma.ca. Find more Aequus Pharmaceuticals email formats with LeadIQ.

How much funding has Aequus Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of January 2026, Aequus Pharmaceuticals has raised $299K in funding. The last funding round occurred on Jul 06, 2023 for $299K.

When was Aequus Pharmaceuticals founded?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals was founded in 2013.

Aequus Pharmaceuticals

Pharmaceutical ManufacturingBritish Columbia, Canada0-1 Employees

We are a growing specialty pharmaceutical company focused on developing and commercializing high-quality, differentiated products. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas.
 
We continue to build our pipeline with new partnerships and have recently added a number of commercial-stage products through in-licensing and distribution agreements.
 
Our commercial programs are supported and guided by insights from patients, physicians, and payers. Aequus’ management team has a proven track record of successfully managing the required clinical development, regulatory approval processes, and marketing of products. We continue to leverage our internal capabilities and know-how to execute an efficient commercial strategy and development plan to drive shareholder value.therapeutic areas including neurology, ophthalmology and transplant. Aequus is developing a pipeline of products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
0-1

Section iconFunding & Financials

  • $299K

    Aequus Pharmaceuticals has raised a total of $299K of funding over 8 rounds. Their latest funding round was raised on Jul 06, 2023 in the amount of $299K.

  • $1M

    Aequus Pharmaceuticals's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $299K

    Aequus Pharmaceuticals has raised a total of $299K of funding over 8 rounds. Their latest funding round was raised on Jul 06, 2023 in the amount of $299K.

  • $1M

    Aequus Pharmaceuticals's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.